⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8811533 | 1.00 | — | — | |
| SCHEMBL7456988 | 0.91 | — | — | |
| SCHEMBL23829882 | 0.82 | — | — | |
| SCHEMBL4395003 | 0.80 | — | — | |
| SCHEMBL8386085 | 0.77 | — | — | |
| SCHEMBL14879619 | 0.77 | — | — | |
| SCHEMBL28359794 | 0.76 | — | — | |
| SCHEMBL2481917 | 0.76 | — | — | |
| SCHEMBL7526984 | 0.76 | — | — | |
| SCHEMBL17870959 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173076-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | UNIV STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
| EP-3237435-B1 | METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR | INST NAT SANTE RECH MED (FR) | 2023-05-24 | — | — | EP | disclosed |
| US-20220073446-A1 | Antigen Delivery Vectors and Constructs | ALTIMMUNE UK LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |
| US-11066353-B2 | Antigen delivery vectors and constructs | ALTIMMUNE UK LTD (GB) | 2021-07-20 | — | — | US | disclosed |
| US-20210206817-A1 | Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2021-07-08 | — | — | US | disclosed |
| EP-3472195-B1 | METABOLICALLY STABLE SPEXIN PEPTIDE ANALOGS | UNIV STRASBOURG (FR) | 2021-05-26 | — | — | EP | disclosed |
| EP-3472191-B1 | METABOLICALLY STABLE FLUOROPEPTIDE ANALOGS | UNIV STRASBOURG (FR) | 2021-05-26 | — | — | EP | disclosed |
| US-20190328887-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | UNIVERSITÉ DE STRASBOURG (FR) | 2019-10-31 | — | — | US | disclosed |
| US-20190135887-A1 | METABOLICALLY STABLE SPEXIN PEPTIDE ANALOGS | UNIVERSITÉ DE STRASBOURG (FR) | 2019-05-09 | — | — | US | disclosed |
| EP-3472191-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | Université de Strasbourg (FR) | 2019-04-24 | — | — | EP | disclosed |
| US-8110540-B2 | Antigen delivery vectors and constructs | IMMUNE TARGETING SYSTEMS LTD. (GB) | 2012-02-07 | — | — | US | disclosed |
| EP-2374477-A1 | Antigen delivery vectors and constructs | Immune Targeting Systems (GB) | 2011-10-12 | — | — | EP | disclosed |
| US-20100183708-A1 | Antigen Delivery Vectors and Constructs | IMMUNE TARGETING SYSTEMS LTD. | 2010-07-22 | — | — | US | disclosed |
| US-20100183650-A1 | Antigen Delivery Vectors and Constructs | IMMUNE TARGETING SYSTEMS LTD. | 2010-07-22 | — | — | US | disclosed |
| US-7687455-B2 | comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy | IMMUNE TARGETING SYSTEMS LTD. (GB) | 2010-03-30 | — | — | US | disclosed |
| CN-1980695-A | Antigen delivery vectors and constructs | IMMUNE TARGETING SYSTEMS (GB) | 2007-06-13 | — | — | CN | disclosed |
| EP-1740207-A2 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | Immune Targeting Systems (GB) | 2007-01-10 | — | — | EP | disclosed |
| US-20060013820-A1 | comprising fluorocarbon vector-antigen, immunogens; vaccines, immunotherapy | ALTIMMUNE UK LIMITED (GB) | 2006-01-19 | — | — | US | disclosed |
| WO-2005099752-A9 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | IMMUNE TARGETING SYSTEMS (GB) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005099752-A2 | ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | IMMUNE TARGETING SYSTEMS (GB) | 2005-10-27 | — | — | WO | disclosed |